Uroprost 0.05 g suppository # 10
Scope of the drug
Genitourinary system
Release form
Suppositories
Manufacturer country
Russia
Package quantity, pcs
ten
Way of introduction
Rectally
Amount in a package
ten
Dosage form
rectal suppositories
Manufacturer
Altpharm, Russia
Structure
active substance: bovine prostate extract - 50 mg
auxiliary components: witepsol W35 (glycerides of saturated fatty acids of vegetable origin).
pharmachologic effect
The drug has anti-inflammatory and antiaggregatory effects, stimulates the muscles of the bladder.
The active ingredients of the prostate extract belong to the group of peptide bioregulators - cytomedins. These drugs are basic peptides with a molecular weight of 1 to 10 kDa. Low molecular weight peptides of para- or autocrine nature, perform the function of trans-specific intra- and intercellular messengers. Peptides of the prostate gland reduce the time of blood coagulation and increase the antiaggregatory activity of the vascular wall, improve blood microcirculation, enhance the fibrinolytic activity of the blood, increase the contractile activity of detrusor myocytes in vivo, in vitro. They have immunomodulatory and immunostimulating effects, enhance the synthesis of antihistamine and antiserotonin antibodies.
The use of peptide bioregulators in the treatment of chronic prostatitis is based on the ability of these drugs to restore microcirculation, to exert an indirect anti-inflammatory effect by increasing the synthesis of antihistamine and antiserotonin antibodies, as well as their immunomodulatory and immunostimulating effects.
Treatment of benign prostatic hyperplasia is based on the most important biological effect of cytomedines: organotropy, which allows.
regulate the processes of differentiation and function of cells in the organ from which they are isolated.
Indications
- chronic prostatitis
- condition before and after operations on the prostate gland
- benign prostatic hyperplasia.
Contraindications
Individual intolerance (including a history of hypersensitivity).
Side effects
The peculiarities of the technology for the isolation of these peptides neutralize their molecular species-specificity, as a result of which the obtained preparations lose their antigenic properties and associated side effects.
Often 1-10%
sometimes - 0.1-1%
rarely - 0.01-0.1%
very rarely - less than 0.01%, including isolated cases.
Very rarely - allergic reactions, often - itching in the anus, sometimes diarrhea, flatulence.
Interaction
No negative interaction was noted.
The drug can be used in combination therapy.
How to take, course of administration and dosage
The drug is used rectally.
Having released the suppository from the contour packaging, it is introduced into the anus after a bowel movement or a cleansing enema.
Apply 1 suppository once a day.
After administration of the drug, it is desirable for the patient to stay in bed for 30-40 minutes.
The duration of treatment is 20 days.
According to indications, repeated courses are possible
it is recommended to carry out no earlier than after 2-4 weeks.
Overdose
Currently, there have been no cases of overdose.
Special instructions
Treatment of chronic prostatitis should be complex, involving the use of various groups of drugs and non-drug treatment methods.
During treatment, it is recommended to analyze the secretion of the prostate gland.
Release form
Torpedo-shaped, from gray with a brownish tint to white with a grayish or yellowish tint.
Storage conditions
In a dark place at a temperature not exceeding 25 В° C.
Keep out of the reach of children.
Shelf life
2 years.
Terms of dispensing from pharmacies
Without recipe
Name ENG
UROPROST
Clinical and pharmacological group
An animal drug used for diseases of the prostate gland
ATX code
Other drugs for the treatment of urological diseases
Dosage
50mg
Structure
active substance: bovine prostate extract - 50 mg
auxiliary components: witepsol W35 (glycerides of saturated fatty acids of vegetable origin).
Storage conditions and periods
In a dark place at a temperature not exceeding 25 degrees.
Expiration date: 2 years
INN / Active ingredient
Prostate extract
Specifications
Scope of the drug
Genitourinary system
Release form
Suppositories
Manufacturer country
Russia
Package quantity, pcs
ten
Way of introduction
Rectally
Vacation conditions
Without recipe
Brand name
Altpharm
The amount of the dosage form in the primary package
5 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Chronic prostatitis treatment
Anatomical and therapeutic characteristics
G04BX Drugs for the treatment of urological diseases other
Dosage form
Rectal suppositories
Dosage (volume) of the substance in the preparation
bovine prostate extract 50 mg
Expiration date in days
730
Package weight, g
twenty
Category
:
Genitourinary tract infections
,
BPH
,
Impotence in men
Mode of application
:
The drug is used rectally.
Having released the suppository from the contour packaging, it is introduced into the anus after a bowel movement or a cleansing enema.
< br> Apply 1 suppository once a day.
< br> After administration of the drug, it is desirable for the patient to stay in bed for 30-40 minutes.
The duration of treatment is 20 days.
< br> According to indications, repeated courses are possible
it is recommended to carry out no earlier than after 2-4 weeks.
Information on technical characteristics, delivery set, country of manufacture